Cargando…
Therapeutic efficacy of isavuconazole in experimental Aspergillus fumigatus endophthalmitis
BACKGROUND: Fungal endophthalmitis remains a significant cause of vision impairment and blindness with poor prognosis, in part, due to delay in diagnosis and limited availability of antifungal agents without ocular toxicity. Thus, it is imperative to evaluate the therapeutic efficacy of newer antifu...
Autores principales: | Guest, John, Singh, Pawan Kumar, Revankar, Sanjay G, Chandrasekar, Pranatharthi H, Kumar, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631991/ http://dx.doi.org/10.1093/ofid/ofx163.633 |
Ejemplares similares
-
Pathobiology of Aspergillus Fumigatus Endophthalmitis in Immunocompetent and Immunocompromised Mice
por: Gupta, Neha, et al.
Publicado: (2019) -
Evaluation of Susceptibility and Innate Immune Response in C57BL/6 and BALB/c Mice During Candida albicans Endophthalmitis
por: Rottmann, Bruce G., et al.
Publicado: (2020) -
Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
por: Khambati, Alisha, et al.
Publicado: (2022) -
2114. Evaluation of Isavuconazole Activity against Non-fumigatus Aspergillus and cryptic Aspergillus species Causing Invasive Infections Worldwide
por: Carvalhaes, Cecilia G, et al.
Publicado: (2023) -
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
por: Natesan, Suganthini Krishnan, et al.
Publicado: (2016)